Vincent S. Khoo

Fulham Road
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 200 publications

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

Journal: European urology

Published: October 23, 2025

A standardised attenuated dosing of 177 lutetium-prostate-specific membrane antigen therapy for patients with metastatic castration-resistant prostate carcinoma and preexisting renal impairment.

A standardised attenuated dosing of 177 lutetium-prostate-specific membrane antigen therapy for patients with metastatic castration-resistant prostate carcinoma and preexisting renal impairment.

Journal: Nuclear medicine communications

Published: October 01, 2025

Predictors of Long-Term Disease-Free Survival With Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.

Predictors of Long-Term Disease-Free Survival With Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.

Journal: International journal of radiation oncology, biology, physics

Published: July 17, 2025

UK real-world data of radium-223 dichloride in metastatic prostate cancer.

UK real-world data of radium-223 dichloride in metastatic prostate cancer.

Journal: Nuclear medicine communications

Published: June 04, 2025

Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial.

Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial.

Journal: European urology oncology

Published: March 03, 2025

Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trial.

Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trial.

Journal: BMJ open

Published: December 26, 2024

A modified Delphi consensus regarding the clinical utility of triplet therapy in patients with metastatic hormone-sensitive prostate cancer patients in the UK.

A modified Delphi consensus regarding the clinical utility of triplet therapy in patients with metastatic hormone-sensitive prostate cancer patients in the UK.

Journal: BMJ open

Published: November 28, 2024

Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study.

Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study.

Journal: European urology oncology

Published: June 04, 2024

Advancing the Paradigm: Oligometastatic Disease and the Impact of Stereotactic Ablative Body Radiotherapy.

Advancing the Paradigm: Oligometastatic Disease and the Impact of Stereotactic Ablative Body Radiotherapy.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: February 02, 2024

Weekly ultra-hypofractionated radiotherapy in localised prostate cancer.

Weekly ultra-hypofractionated radiotherapy in localised prostate cancer.

Journal: Clinical and translational radiation oncology

Published: January 19, 2024

COmparing Urolift and Standard Transurethral resection of prostate Ahead of Radiotherapy in men with urinary symptoms secondary to prostate enlargement in Southwest London and North Cumbria (CO-STAR): a study protocol for a randomised feasibility study.

COmparing Urolift and Standard Transurethral resection of prostate Ahead of Radiotherapy in men with urinary symptoms secondary to prostate enlargement in Southwest London and North Cumbria (CO-STAR): a study protocol for a randomised feasibility study.

Journal: BMJ open

Published: October 06, 2023

ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy.

ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy.

Journal: Clinical and translational radiation oncology

Published: September 22, 2023

Showing 1-12 of 200

Last Updated: 09/26/2026